大成生化科技(00809.HK):法院以中國銀行錦州支行為受益人頒佈命令以保全大成糖業集團資產
格隆匯9月24日丨大成生化科技(00809.HK)發佈公吿,於本公吿日期,錦州大成貸款項下的未償還本金金額約為人民幣1980萬元,而錦州元成貸款項下的未償還本金金額則約為人民幣3000萬元。大成糖業集團收到遼寧省瀋陽市中級人民法院發出的傳訊令狀,須出席中國銀行錦州支行就償還大成糖業集團所欠付或擔保的錦州大成貸款及錦州元成貸款項下未償還本金金額及利息所提起的申訴的聆訊。
同時,瀋陽市中級法院以中國銀行錦州支行為受益人頒佈命令,以保全大成糖業集團的資產,其總金額相當於錦州大成貸款及錦州元成貸款的未償還本金金額及利息合共人民幣5552萬元,佔大成糖業集團於2021年6月30日的資產總值約7.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.